Financialsexperimental
Quanex Building Products CORP (NX). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in thousands · shares in thousands · per-share amounts in USD
| Income Statement | Q3 FY26 31 Jul 2026 | Q2 FY26 30 Apr 2026 | Q1 FY26 31 Jan 2026 | Q4 FY25 31 Oct 2025 | Q3 FY25 31 Jul 2025 | Q2 FY25 30 Apr 2025 | Q1 FY25 31 Jan 2025 | Q4 FY24 31 Oct 2024 | Q3 FY24 31 Jul 2024 | Q2 FY24 30 Apr 2024 | Q1 FY24 31 Jan 2024 | Q4 FY23 31 Oct 2023 | Q3 FY23 31 Jul 2023 | Q2 FY23 30 Apr 2023 | Q1 FY23 31 Jan 2023 | Q4 FY22 31 Oct 2022 | Q3 FY22 31 Jul 2022 | Q2 FY22 30 Apr 2022 | Q1 FY22 31 Jan 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 501,845 | 462,367 | 409,089 | 495,273 | 452,478 | 400,044 | 280,345 | 266,201 | 239,155 | 299,640 | 273,535 | 261,916 | 324,037 | 322,893 | 267,040 | ||||
| Cost of sales (excluding depreciation and amortization) | 360,380 | 344,575 | 310,562 | 357,305 | 321,096 | 307,728 | 209,441 | 199,963 | 187,723 | 221,065 | 206,372 | 210,149 | 251,446 | 249,651 | 211,834 | ||||
| Selling, general and administrative | 70,837 | 74,432 | 71,426 | 69,008* | 71,270 | 70,333 | 66,650 | 86,891* | 36,509 | 34,707 | 32,363 | 29,326* | 30,516 | 27,371 | 36,744 | 29,334* | 28,822 | 28,129 | 30,823 |
| Restructuring charges | 0 | 0 | 0 | -16* | 1,367 | 936 | 7,904 | 0* | 0 | 0 | 0 | ||||||||
| Depreciation and amortization | 24,138 | 24,650 | 24,249 | 25,630* | 33,882 | 19,192 | 24,740 | 27,329* | 10,953 | 10,894 | 11,152 | 11,194* | 10,596 | 10,456 | 10,620 | 9,555* | 9,734 | 10,563 | 10,257 |
| Goodwill impairment charges | 0 | 302,284 | |||||||||||||||||
| Operating income (loss) | 46,490 | 18,710 | 2,852 | 42,940* | -270,835 | 40,921 | -6,978 | 2,830* | 23,442 | 20,637 | 7,917 | 39,499* | 37,463 | 29,336 | 4,403 | 28,570* | 34,035 | 34,550 | 14,126 |
| Interest expense | -11,978 | -12,042 | -12,367 | -13,468* | -14,218 | -13,940 | -14,186 | -17,697* | -878 | -950 | -1,068 | -1,565* | -2,068 | -2,244 | -2,259 | -710* | -724 | -602 | -523 |
| Other, net | -93 | 448 | 5,617 | 5,246* | 855 | -159 | 1,229 | -2,671* | 9,474 | 4 | 1,042 | -6,110* | 402 | -29 | 218 | 136* | 398 | 453 | 54 |
| Income (loss) before income taxes | 34,419 | 7,116 | -3,898 | 34,718* | -284,198 | 26,822 | -19,935 | 32,038 | 19,691 | 7,891 | 35,797 | 27,063 | 2,362 | 33,709 | 34,401 | 13,657 | |||
| Income tax (expense) benefit | -7,915 | -3,766 | -173 | -15,147* | 8,191 | -6,307 | 5,050 | 3,621* | -6,688 | -4,314 | -1,642 | -4,442* | -4,099 | -5,551 | -453 | -3,329* | -7,801 | -7,879 | -2,418 |
| Net income (loss) | 26,504 | 3,350 | -4,071 | 19,571* | -276,007 | 20,515 | -14,885 | -13,917* | 25,350 | 15,377 | 6,249 | 27,382* | 31,698 | 21,512 | 1,909 | 24,667* | 25,908 | 26,522 | 11,239 |
| Basic and diluted earnings (loss) per common share | 0.58 | 0.07 | -0.09 | -6.04 | 0.44 | -0.32 | 0.77 | 0.47 | 0.19 | 0.97 | 0.65 | 0.06 | 0.79 | 0.8 | 0.34 | ||||
| Diluted earnings (loss) per common share | 0.58 | 0.07 | -0.09 | -6.04 | 0.44 | -0.32 | 0.77 | 0.46 | 0.19 | 0.96 | 0.65 | 0.06 | 0.78 | 0.8 | 0.34 | ||||
| Basic (in shares) | 45,461 | 45,483 | 45,456 | 45,691 | 46,483 | 47,015 | 32,876 | 32,870 | 32,825 | 32,716 | 32,858 | 32,951 | 32,999 | 33,157 | 33,124 | ||||
| Diluted (in shares) | 45,648 | 45,658 | 45,456 | 45,691 | 46,563 | 47,015 | 33,106 | 33,103 | 33,043 | 32,919 | 33,017 | 33,137 | 33,173 | 33,291 | 33,298 | ||||
| Cash dividends per share (in usd per share) | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |